USD 450

Product Type

Industry Statistics

Release Date

15 March 2021

Region

Asia Pacific

Release Year

2021

Table of Contents
    Add a header to begin generating the table of contents

    Description

    The cardiovascular pharmaceutical market in China in terms of revenue is set to grow by US$ 7 billion during 2021-2027, growing at a compound annual growth rate (CAGR) of 3.3% during the forecast period, according to data and analytics company StrategyHelix.

    The report provides up-to-date market size data for period 2017-2020 and forecast to 2027 covering key market aspects like sales value for cardiovascular pharmaceutical. The China cardiovascular pharmaceutical market is segmented on the basis of distribution channel, type. By distribution channel, it is categorized into hospital, and retail. By type, the cardiovascular pharmaceutical market is divided into biologics, chemical medicine, and traditional Chinese medicine.

    The report has profiled some of the key players of the market such as Bayer AG, Chia Tai Tianqing Pharmaceutical Group Co. Ltd., Merck KGaA, Novartis International AG, Pfizer Inc., Qilu Pharmaceutical Co. Ltd., Sanofi S.A., Shanghai Pharmaceuticals Holding Co. Ltd., Zhejiang Huahai Pharmaceutical Co. Ltd..

    The report is an invaluable resource for companies and organizations active in this industry. It provides a cohesive picture of the cardiovascular pharmaceutical market to help drive informed decision making for industry executives, policy makers, academic, and analysts.


    Report Scope

    Distribution channel: hospital, and retail
    Type: biologics, chemical medicine, and traditional Chinese medicine
    Years Considered: this report covers the period 2017 to 2027


    Key Benefits for Stakeholders

    Get a comprehensive picture of the China cardiovascular pharmaceutical market
    Pinpoint growth sectors and trends for investment
    Understand what the future of the cardiovascular pharmaceutical market in China looks like
    Identify the competitive landscape and window of opportunity


    Table of Contents

    1. Market Definition
    2. Research Methodology
    3. Market Data & Outlook
    3.1 Market Value
    3.2 Market Value Forecast
    4. Cardiovascular Pharmaceutical Market by Distribution Channel
    4.1 Hospital
    4.2 Retail
    5. Cardiovascular Pharmaceutical Market by Type
    5.1 Biologics
    5.2 Chemical Medicine
    5.3 Traditional Chinese Medicine
    6. Company Profiles
    6.1 Bayer AG
    6.2 Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
    6.3 Merck KGaA
    6.4 Novartis International AG
    6.5 Pfizer, Inc.
    6.6 Qilu Pharmaceutical Co., Ltd.
    6.7 Sanofi S.A.
    6.8 Shanghai Pharmaceuticals Holding Co., Ltd.
    6.9 Zhejiang Huahai Pharmaceutical Co., Ltd.
    7. Appendix
    7.1 About StrategyHelix
    7.2 Disclaimer


    StrategyHelix Black LOGO

    REQUEST SAMPLE

    Please fill out our form and we will get back to you.

    Cardiovascular Pharmaceutical Market in China 2021

    StrategyHelix Black LOGO

    CUSTOM RESEARCH

    Custom projects can be researched to match your unique needs.

    Cardiovascular Pharmaceutical Market in China 2021

    login